Clinical Trial Update: Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses adding Everolimus to multiagent re-induction chemotherapy in pediatric patients with Acute Lymphoblastic Leukemia. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED